Comparison of high sensitivity micro differential scanning calorimetry with X-ray powder diffractometry and FTIR spectroscopy for the characterization of pharmaceutically relevant non-crystalline materials

Pharmazie

Volumn 61, Issue 4, 2006, Pages 336-340

  Song, M ^a   Liebenberg, W ^b   De Villiers, Melgardt ^a,c  

^a UNIVERSITY OF LOUISIANA   (United States)

^b NORTH WEST UNIVERSITY   (South Africa)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMPHENICOL PALMITATE; EXCIPIENT; NIFEDIPINE; POLYGLACTIN;

ARTICLE; CRYSTAL; CRYSTALLIZATION; DIFFERENTIAL SCANNING CALORIMETRY; DRUG FORMULATION; FOURIER TRANSFORMATION; INFRARED SPECTROSCOPY; INTERMETHOD COMPARISON; MELTING POINT; X RAY POWDER DIFFRACTION;

CALORIMETRY, DIFFERENTIAL SCANNING; CHEMISTRY, PHARMACEUTICAL; CHLORAMPHENICOL; CRYSTALLIZATION; LACTIC ACID; NIFEDIPINE; PHARMACEUTICAL PREPARATIONS; POLYGLYCOLIC ACID; POLYMERS; REPRODUCIBILITY OF RESULTS; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; X-RAY DIFFRACTION;

EID: 33645790073     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Ahmed H, Buckton G, Rawlins DA (1996) The use of isothermal microcalorimetry in the study of small degrees of amorphous content of a hydrophobic powder. Int J Pharm 130: 195-201.
2. Allais C, Keller G, Lesieur P, Ollivon M, Artzner F (2003) X-ray diffraction/Calorimetry coupling. J Thermal Anal Cal 74: 723-728.
3. Bergese P, Colombo I, Gervasoni D, Depero LE (2003) Assessment of the X-ray diffraction-absoption method for quantitative analysis of largely amorphous pharmaceutical composites. J Appl Crys 36: 74-79.
4. Bernstein J (2002) Polymorphism in Molecular Crsytals, Oxford Science Publications, Oxford, pp. 243-244.
5. Briggner LE, Buckton G, Bystrom K, Darcy P (1994) The use of isothermal microcalorimetry in the study of changes in crystallinity induced during the processing of powders. Int J Pharm 105: 125-135.
6. British Pharmacopoeia (2003) Her Majesty's Stationary Office. London, United Kingdom.
7. Buckton G, Darcy P (1999) Assessment of disorder in crystalline powders. A review of analytical techniques and their application. Int J Pharm 179: 141-158.
8. Caira MR, Robbertse Y, Bergh JJ, Song M, De Villiers MM (2003) Structural characterization, physicochemical properties, and thermal stability of three crystal forms of nifedipine. J Pharm Sci 92: 2519-2533.
9. Clas S-D, Dalton CR, Hancock BC (1999) Differential scanning calorimetry: applications in drug development. Pharm Sci Tech Tod 2: 311-320.
10. Giron D, Edel B, Piechon P (1990) X-ray quantitative determination of polymorphism in pharmaceuticals. Mol Crys Liq Crys 187: 557-567.
11. Hancock BC, Parks M (2000) What is the true solubility advantage for amorphous pharmaceuticals? Pharm Res 17: 397-404.
12. Kawahami K, Numa T, Ida Y (2002) Assessment of amorphous content by microcalorimetry. J Pharm Sci 91: 417-423.
13. Keymolen B, Ford JL, Powell MW, Rajabi-Siahboomi AR (2003) Investigation of the polymorphic transformations from glassy nifedipine. Therm Acta 397: 103-117.
14. Leitao MLP, Canotilho J, Sousa A, Pais AACC, Sousa AT, Simoes RJ (2003) Infrared spectroscopy and the characterization of terfenadine crystallized from solvents. J Thermal Anal Cal 73: 763-774.
15. Royall PG, Kett VL, Andrews CS, Craig DQM (2001) Identification of crystalline and amorphous regions in low molecular weight materials using microthermal analysis. J Phys Chem B 105: 7021-7026.
16. Song M, De Villiers MM (2004) Effect of a change in crystal polymorph on the degree of adhesion between micronized drug particles and large homogenous carrier particles during an interactive mixing process. Pharm Dev Tech 9: 387-398.
17. Swartz ME, Krull IS (1997) Analytical Method Development and Validation, Dekker, New York, p. 53.
18. Tanninen VP, Yliruusi J (1992) X-ray powder diffraction profile fitting in quantitative determination of two polymorphs from their powder mixture. Int J Pharm 81: 169-177.
19. The United States Pharmacopeia (2000) United States Pharmacopeial Convention, Inc., Rockville, p. 379.
20. Yonemochi E, Ueno Y, Ohmae T, Oguchi T, Nakajima SI, Yamamoto K (1997) Evaluation of amorphous ursodeoxycholic acid by thermal methods. Pharm Res 14: 798-803.